Premium
Effects of Vitamin D3 on the Expression of Growth‐Related Oncogene‐α in THP‐1 Cells and Human Primary Monocytes
Author(s) -
Kuo YuTing,
Jan RenLong,
Kuo ChangHung,
Kuo PoLin,
Wang WeiLi,
Huang MingYii,
Chen HuanNan,
Hung ChihHsing
Publication year - 2012
Publication title -
journal of food science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.772
H-Index - 150
eISSN - 1750-3841
pISSN - 0022-1147
DOI - 10.1111/j.1750-3841.2011.02532.x
Subject(s) - thp1 cell line , primary (astronomy) , vitamin , oncogene , biology , chemistry , endocrinology , cell culture , biochemistry , genetics , gene , cell cycle , physics , astronomy
Asthma and many autoimmune diseases, such as systemic lupus erythematosus, have been reported to associate with vitamin D deficiency recently. Growth‐related oncogene‐α (GRO‐α)/CXCL1, a neutrophil‐related chemokine, have an important influence on the chronic inflammation of these diseases. It is unknown whether vitamin D has regulatory effects on GRO‐α expression in human monocytes. To this end, the human monocytic leukemia cell line, THP‐1, and human primary monocytes were pretreated with 1α, 25‐(OH) 2 D 3 , and was stimulated with lipopolysaccharide (LPS). Supernatants were collected to determine GRO‐α level by ELISA. The intracellular signaling was investigated by nuclear factor (NF)‐κB inhibitor, the mitogen‐activated protein kinase (MAPK) inhibitors, and Western blot. In our studies, LPS‐induced GRO‐α was significantly enhanced in THP‐1 cells, but suppressed in human primary monocytes by 1α,
25‐(OH) 2 D 3 . Western blotting revealed that 1α, 25‐(OH) 2 D 3 increased LPS‐stimulated pp38 expression in THP‐1 cells, but suppressed LPS‐stimulated pMEK1/2‐pERK and pJNK in human primary monocytes. In conclusion, the opposite effects of 1α, 25‐(OH) 2 D 3 on GRO‐α expression in THP‐1 cells and human primary monocytes indicated that the data from THP‐1 cells should be further confirmed by human primary monocytes. Moreover, vitamin D3 may have potentiality in treating GRO‐α‐related chronic inflammatory diseases, like asthma and autoimmune diseases.